Publicador de contenidos

Investigación e Innovación Programas
Salud Materna, Infantil y Reproductiva

MIBio

Identification of Prematurity and Pre-Eclampsia as Causes of Mortality

Proyecto MIBio
Duración
08/10/2019 - 31/05/2022
Coordinador
Natalia Rakislova
Financiadores
Bill & Melinda Gates Foundation

The MIBio project (INV-002394) is coordinated by the Barcelona Institute of Global Health (ISGlobal) and is carried out in collaboration with the Faculty of Medicine of Eduardo Mondlane University (UEM, Mozambique), the Maputo Central Hospital (MCH, Mozambique), the Manhiça Health Research Center/Fundação Manhiça (CISM/FM, Mozambique) and Hospital Clínic of Barcelona (FCRB, Spain).

The overall goal of the MIBio project is to potentially reduce maternal and perinatal morbidity and mortality associated with preterm birth and/or preeclampsia in a low-resource setting by improving the accuracy of postmortem identification of these conditions. Minimally Invasive Tissue Sampling (MITS) enriched with the determination of angiogenic biomarkers and post-mortem ultrasound could serve as a perinatal mortality surveillance tool in geographic areas with a high burden of pregnancy-related hypertensive disorders and prematurity.

Additionally, the project also aims at contributing to the capacity building of young African researchers and establishing sustainable networks to tackle preeclampsia and prematurity.

Total Funding

1,499,945.00 USD

Nuestro equipo

Coordinator

  • Natalia Rakislova
    Natalia Rakislova

ISGlobal Team

  • Raquel González Alvarez
    Raquel González Alvarez
  • Clara Menéndez Santos
    Clara Menéndez Santos
  • Jaume Ordi
    Jaume Ordi Research Professor

Otros proyectos

Ver proyectos pasados

CaDMIA-plus

Validación continuada de la autopsia mínimamente invasiva (MIA) para la investigación de la causa de muerte en niños pequeños, y desarrollo de un centro de investigación y formación sobre el estudio de la causa de muerte

MAMAH

Improving Maternal and Infant Health by reducing malaria risks in African women: evaluation of the safety and efficacy of dihydroartemisinin-piperaquine for intermittent preventive treatment of malaria in HIV-infected pregnant women

ICARIA

Improving Care through Azithromycin Research for Infants in Africa

MULTIPLY

MULTIple doses of IPTi Proposal: a Lifesaving high Yield intervention

MA-CoV

Prevalence and impact of SARS-CoV-2 infection on maternal and infant health in African populations

IPERVAC-SL

Impact of perceptions of COVID-19 vaccines on health-seeking behaviours in Sierra Leone

RESPIRE

Respiratory syncytial virus (RSV) in African pregnant women and children

VITAL

Towards preparedness for new maternal vaccinations: Understanding barriers and facilitators to maternal vaccine acceptance

HIV drug resistance (HIVDR)

Description of HIV drug resistance patterns and its association with the risk of HIV mother to child transmission among pregnant women from southern Mozambique

PROTECT

PReparing for Optimal Phase III/IV maTErnal Group B StreptococCal vaccine Trials in Africa